These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22236850)

  • 1. Rifampicin-monoresistant Mycobacterium tuberculosis disease among children in Cape Town, South Africa.
    Dramowski A; Morsheimer MM; Jordaan AM; Victor TC; Donald PR; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):76-81. PubMed ID: 22236850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa.
    Mukinda FK; Theron D; van der Spuy GD; Jacobson KR; Roscher M; Streicher EM; Musekiwa A; Coetzee GJ; Victor TC; Marais BJ; Nachega JB; Warren RM; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):196-202. PubMed ID: 22236920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.
    Seddon JA; Hesseling AC; Marais BJ; Jordaan A; Victor T; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):928-33. PubMed ID: 22583610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases.
    Schaaf HS; Marais BJ; Whitelaw A; Hesseling AC; Eley B; Hussey GD; Donald PR
    BMC Infect Dis; 2007 Nov; 7():140. PubMed ID: 18047651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
    Coovadia YM; Mahomed S; Pillay M; Werner L; Mlisana K
    PLoS One; 2013; 8(11):e77712. PubMed ID: 24223122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for rifampin-monoresistant tuberculosis: A case-control study.
    Sandman L; Schluger NW; Davidow AL; Bonk S
    Am J Respir Crit Care Med; 1999 Feb; 159(2):468-72. PubMed ID: 9927359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa.
    Salaam-Dreyer Z; Streicher EM; Sirgel FA; Menardo F; Borrell S; Reinhard M; Doetsch A; Cudahy PGT; Mohr-Holland E; Daniels J; Dippenaar A; Nicol MP; Gagneux S; Warren RM; Cox H
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0036421. PubMed ID: 34460307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and outcome in children admitted to a TB hospital in the Western Cape--the influence of HIV infection and drug resistance.
    Soeters M; de Vries AM; Kimpen JL; Donald PR; Schaaf HS
    S Afr Med J; 2005 Aug; 95(8):602-6. PubMed ID: 16201005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevelance of rifampin-monoresistant tuberculosis: a retrospective analysis among Iranian pulmonary tuberculosis patients.
    Velayati AA; Farnia P; Mozafari M; Sheikholeslami MF; Karahrudi MA; Tabarsi P; Hoffner S
    Am J Trop Med Hyg; 2014 Jan; 90(1):99-105. PubMed ID: 24189362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampicin mono-resistant Mycobacterium tuberculosis in Bujumbura, Burundi: results of a drug resistance survey.
    Sanders M; Van Deun A; Ntakirutimana D; Masabo JP; Rukundo J; Rigouts L; Fissette K; Portaelst F
    Int J Tuberc Lung Dis; 2006 Feb; 10(2):178-83. PubMed ID: 16499257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Morocco.
    Kourout M; Chaoui I; Sabouni R; Lahlou O; El Mzibri M; Jordaan A; Victor TC; Akrim M; El Aouad R
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1440-2. PubMed ID: 19861020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study.
    Zar HJ; Workman L; Isaacs W; Dheda K; Zemanay W; Nicol MP
    Lancet Glob Health; 2013 Aug; 1(2):e97-e104. PubMed ID: 25104164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance provides insight into epidemiology and spectrum of culture-confirmed mycobacterial disease in children.
    Schaaf HS; Garcia-Prats AJ; du Preez K; Rautenbach C; Hesseling AC
    Int J Tuberc Lung Dis; 2016 Sep; 20(9):1249-56. PubMed ID: 27510254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical course of human immunodeficiency virus type 1 associated pulmonary tuberculosis during short-course antituberculosis therapy.
    Schwander SK; Dietrich M; Mugyenyi P; Kityo C; Okwera A; Johnson J; Nsubuga P; Ruesch-Gerdes S; Whalen C
    East Afr Med J; 1997 Sep; 74(9):543-8. PubMed ID: 9487427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of rifampicin-resistant Mycobacterium tuberculosis among human-immunodeficiency-virus-seropositive patients and their treatment outcomes.
    Vidyaraj CK; Chitra A; Smita S; Muthuraj M; Govindarajan S; Usharani B; Anbazhagi S
    J Epidemiol Glob Health; 2017 Dec; 7(4):289-294. PubMed ID: 29110871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular detection and characterization of resistant genes in Mycobacterium tuberculosis complex from DNA isolated from tuberculosis patients in the Eastern Cape province South Africa.
    Bhembe NL; Nwodo UU; Govender S; Hayes C; Ndip RN; Okoh AI; Green E
    BMC Infect Dis; 2014 Sep; 14():479. PubMed ID: 25186245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study.
    Cox H; Salaam-Dreyer Z; Goig GA; Nicol MP; Menardo F; Dippenaar A; Mohr-Holland E; Daniels J; Cudahy PGT; Borrell S; Reinhard M; Doetsch A; Beisel C; Reuter A; Furin J; Gagneux S; Warren RM
    Lancet Microbe; 2021 Nov; 2(11):e584-e593. PubMed ID: 34766068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of 'Ribolola': a household tuberculosis contact tracing programme in North West Province, South Africa.
    Thind D; Charalambous S; Tongman A; Churchyard G; Grant AD
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1643-8. PubMed ID: 23131263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifampin monoresistant tuberculosis and HIV comorbidity in California, 1993-2008: a retrospective cohort study.
    Prach LM; Pascopella L; Barry PM; Flood J; Porco TC; Hopewell PC; Metcalfe JZ
    AIDS; 2013 Oct; 27(16):2615-22. PubMed ID: 23842135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.